The mean of WBC, LYM, MCH, and BLAST levels was higher in AML patients compared to the healthy group; in contrast, the mean of LYM%, RBC, HCT, and PLT levels was higher in the control group compared to the patient’s group (Fig. 1A). The gene discussed is PMCH; the disease is acute myeloid leukemia.